Christoffer Gebhardt Selected Research

Christoffer Gebhardt Research Topics

Disease

48	Melanoma (Melanoma, Malignant) 05/2024 - 05/2014
38	Neoplasms (Cancer) 03/2024 - 06/2002
13	Neoplasm Metastasis (Metastasis) 01/2023 - 05/2003
8	Carcinogenesis 12/2019 - 06/2002
6	Skin Neoplasms (Skin Cancer) 01/2023 - 01/2017
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 05/2003
5	Inflammation (Inflammations) 04/2018 - 11/2006
4	Uveal melanoma 12/2023 - 06/2021
3	Disease Progression 04/2024 - 01/2018
2	Cytokine Release Syndrome 12/2023 - 01/2023
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2023
2	Merkel Cell Carcinoma 11/2022 - 12/2021
2	Circulating Neoplastic Cells 01/2020 - 04/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024
1	Hemangiosarcoma (Angiosarcoma) 02/2024
1	Bullous Pemphigoid (Pemphigoid) 02/2024
1	Sepsis (Septicemia) 12/2023
1	Fever (Fevers) 01/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023
1	Basal Cell Carcinoma (Rodent Ulcer) 09/2022
1	Microsatellite Instability 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hemolysis 01/2020
1	Pigmented Nevus (Melanocytic Nevus) 12/2019
1	Fibrosis (Cirrhosis) 10/2017
1	Idiopathic Pulmonary Fibrosis 10/2017

Drug/Important Bio-Agent (IBA)

16	Immune Checkpoint InhibitorsIBA 04/2024 - 10/2020
14	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2016
14	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2006
4	IpilimumabIBA 04/2024 - 12/2015
4	pembrolizumabIBA 02/2024 - 11/2016
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 05/2019
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 05/2016
4	CytokinesIBA 01/2023 - 11/2006
4	Circulating Tumor DNAIBA 01/2022 - 01/2018
4	LigandsIBA 01/2018 - 02/2008
4	Phorbol EstersIBA 10/2010 - 06/2002
3	trametinibIBA 05/2024 - 05/2014
3	dabrafenibIBA 05/2024 - 12/2014
3	AntigensIBA 01/2023 - 11/2015
3	AntibodiesIBA 01/2021 - 01/2017
3	VemurafenibIBA 01/2015 - 05/2014
2	NivolumabIBA 04/2024 - 11/2022
2	tebentafuspIBA 12/2023 - 01/2023
2	cyclopropapyrroloindoleIBA 01/2023 - 11/2022
2	avelumabIBA 11/2022 - 12/2021
2	Mitogen-Activated Protein KinasesIBA 05/2019 - 01/2018
2	ChemokinesIBA 01/2018 - 11/2016
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2017 - 11/2016
2	Messenger RNA (mRNA)IBA 04/2006 - 06/2002
2	CarcinogensIBA 07/2005 - 05/2003
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 07/2005 - 06/2002
1	C-Reactive ProteinIBA 03/2024
1	dupilumabIBA 02/2024
1	cemiplimabIBA 12/2023
1	DisintegrinsIBA 01/2023
1	EnzymesIBA 01/2023
1	HLA-A Antigens (HLA-A)IBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	von Willebrand FactorIBA 01/2023
1	Infliximab (Remicade)FDA Link 01/2023
1	ThrombospondinsIBA 01/2023
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Eosinophil PeroxidaseIBA 11/2022
1	Eosinophil Cationic ProteinIBA 11/2022
1	Complement C6 (Complement 6)IBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2021
1	Circulating MicroRNAIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Histone MethyltransferasesIBA 12/2019
1	Histones (Histone)IBA 12/2019
1	Lysine (L-Lysine)FDA Link 12/2019
1	Complementary DNA (cDNA)IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 04/2018
1	ParaffinIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	InterferonsIBA 01/2018
1	Chemokine ReceptorsIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 11/2017
1	Hyaluronic Acid (Hyaluronan)IBA 11/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2017
1	CC ChemokinesIBA 08/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 01/2017

Therapy/Procedure

31	Therapeutics 05/2024 - 12/2014
11	Immunotherapy 04/2024 - 11/2014
1	Surgical Amputation (Amputations) 02/2024
1	Neoadjuvant Therapy 02/2024
1	Palliative Care (Palliative Therapy) 01/2022
1	Aftercare (After-Treatment) 06/2021
1	Retreatment 10/2020
1	Extracorporeal Shockwave Therapy 04/2018